BioSpace News Archive

Fact.MR has published a latest research report about the overall market dynamics of the global oligonucleotide synthesis market.

Acupuncture is an ancient Chinese medical technique that makes use of needles to alleviate pain, cure some other ailments.

Chronic diseases often lead to catastrophic damage to vital organs. This damage is usually irreversible and leads to lifetime dependency on medicines.

Dr. Shujie Cui has developed a (N+S) Antigen test with great sensitivity and is planning to create the first Saliva N+S Antigen Test

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced interim results from the biliary tract cancers cohort of the ongoing SUMMIT trial of neratinib at the virtual 2021 Gastrointestinal Cancers Symposium hosted by the American Society of Clinical Oncology (ASCO GI) that is currently taking place. The presentation, entitled, “Targeting HER2 (ERBB2) mutation-positive advanced biliary tract cancers wit

ViewRay, Inc. (NASDAQ: VRAY) (the “Company”) today announced that members of management will be participating in a fireside chat at the B. Riley Oncology Investor Conference on Wednesday, January 20, 2021.

- Signs distribution agreement with Galaxy Pharma Ltd., the clear market leader of infertility products and services in Pakistan - Seeks to expand access to infertility care in the fifth most populous country in the world, Pakistan, with approximately 212 million people

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Executive Chairman and Chief Executive Officer, will participate in a fireside chat during the B. Riley Securities Oncology Investor Conference being held virtually. The fireside chat is scheduled to take place on Wednesday, January 20, 2021 at 10:00 AM ET. A live webcast of this presentation will be available on the Events page, located within the Investors

AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it has rescheduled its investor conference call for 11:00 a.m. Eastern Time on Thursday, January 21, 2021 to discuss the recently announced commencement of the treatment of subjects with COVID-19-induced chronic fatigue-like symptoms in the amended AMP-511 trial, recent accomplishments and upcoming milestones. Investors and other interested parties are invited to submit questions

Nuance Communications, Inc. (NASDAQ: NUAN) today announced that it will release its first quarter fiscal 2021 results on Monday, February 8, 2021 after the market close.